Loading
Latest filing published 15 Sept 2026 for Aquestive Therapeutics, Inc., €211k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel Barber appears in our data through filings on Aquestive Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 15 June 2026 to 15 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 15 September 2026, the filings show a transaction worth €211k in Aquestive Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations